Maurizio Pellecchia

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 23

Top Venues

Journal of medicinal chemistry

ACS chemical biology

Molecules (Basel, Switzerland)

ChemMedChem

University of California

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California Dec 17 2015

United States

Professor :: Biomedical Sciences Division

Publications

Giulia Alboreggia, Parima Udompholkul, Carlo Baggio, Kendall Muzzarelli, Zahra Assar, Maurizio Pellecchia
Histidine-Covalent Stapled Alpha-Helical Peptides Targeting hMcl-1. Journal of medicinal chemistry 67 (10) (2024)
Giulia Alboreggia, Parima Udompholkul, Carlo Baggio, Kendall Muzzarelli, Zahra Assar, Maurizio Pellecchia
Histidine-Covalent Stapled Alpha-Helical Peptides Targeting hMcl-1. Journal of medicinal chemistry 67 (10) (2024)
Giulia Alboreggia, Parima Udompholkul, Carlo Baggio, Kendall Muzzarelli, Zahra Assar, Maurizio Pellecchia
Histidine-Covalent Stapled Alpha-Helical Peptides Targeting hMcl-1. Journal of medicinal chemistry 67 (10) (2024)
Giulia Alboreggia, Parima Udompholkul, Carlo Baggio, Kendall Muzzarelli, Zahra Assar, Maurizio Pellecchia
Histidine-Covalent Stapled Alpha-Helical Peptides Targeting hMcl-1. Journal of medicinal chemistry (2024)
Parima Udompholkul, Ana Garza-Granados, Giulia Alboreggia, Carlo Baggio, Jack McGuire, Scott D Pegan, Maurizio Pellecchia
Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist. Journal of medicinal chemistry (2023)
Giulia Alboreggia, Parima Udompholkul, Carlo Baggio, Maurizio Pellecchia
Mixture-Based Screening of Focused Combinatorial Libraries by NMR: Application to the Antiapoptotic Protein hMcl-1. Journal of medicinal chemistry (2023)
Carlo Baggio, Parima Udompholkul, Luca Gambini, Maurizio Pellecchia
Targefrin: A Potent Agent Targeting the Ligand Binding Domain of EphA2. Journal of medicinal chemistry 65 (22) (2022)
Parima Udompholkul, Carlo Baggio, Luca Gambini, Yu Sun, Ming Zhao, Robert M Hoffman, Maurizio Pellecchia
Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates. Molecules (Basel, Switzerland) 26 (12) (2021)
Parima Udompholkul, Carlo Baggio, Luca Gambini, Giulia Alboreggia, Maurizio Pellecchia
Lysine Covalent Antagonists of Melanoma Inhibitors of Apoptosis Protein. Journal of medicinal chemistry 64 (21) (2021)
Carlo Baggio, Anna Kulinich, Cassandra N Dennys, Rochelle Rodrigo, Kathrin Meyer, Iryna Ethell, Maurizio Pellecchia
NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands. Journal of medicinal chemistry 64 (15) (2021)
Luca Gambini, Parima Udompholkul, Carlo Baggio, Aruljothi Muralidharan, Nikola Kenjić, Zahra Assar, J Jefferson P Perry, Maurizio Pellecchia
Design, Synthesis, and Structural Characterization of Lysine Covalent BH3 Peptides Targeting Mcl-1. Journal of medicinal chemistry 64 (8) (2021)
Carlo Baggio, Parima Udompholkul, Luca Gambini, Jennifer Jossart, Ahmed F Salem, Maria Håkansson, J Jefferson P Perry, Maurizio Pellecchia
N-locking stabilization of covalent helical peptides: Application to Bfl-1 antagonists. Chemical biology & drug design 95 (4) (2020)
Ahmed F Salem, Luca Gambini, Parima Udompholkul, Carlo Baggio, Maurizio Pellecchia
Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents. Pharmaceuticals (Basel, Switzerland) 13 (5) (2020)
Luca Gambini, Parima Udompholkul, Ahmed F Salem, Carlo Baggio, Maurizio Pellecchia
Stability and Cell Permeability of Sulfonyl Fluorides in the Design of Lys-Covalent Antagonists of Protein-Protein Interactions. ChemMedChem 15 (22) (2020)
Carlo Baggio, Jalene V Velazquez, Marco Fragai, Tara M Nordgren, Maurizio Pellecchia
Therapeutic Targeting of MMP-12 for the Treatment of Chronic Obstructive Pulmonary Disease. Journal of medicinal chemistry 63 (21) (2020)
Elisa Barile, Carlo Baggio, Luca Gambini, Sergey A Shiryaev, Alex Y Strongin, Maurizio Pellecchia
Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming. Molecules (Basel, Switzerland) 25 (10) (2020)
Carlo Baggio, Parima Udompholkul, Luca Gambini, Ahmed F Salem, Jennifer Jossart, J Jefferson P Perry, Maurizio Pellecchia
Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy. Journal of medicinal chemistry 62 (20) (2019)
Luca Gambini, Carlo Baggio, Parima Udompholkul, Jennifer Jossart, Ahmed F Salem, J Jefferson P Perry, Maurizio Pellecchia
Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues. Journal of medicinal chemistry 62 (11) (2019)
Carlo Baggio, Luca Gambini, Parima Udompholkul, Ahmed F Salem, Alexander Aronson, Ada Dona, Estelle Troadec, Flavia Pichiorri, Maurizio Pellecchia
Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach. Journal of medicinal chemistry 61 (14) (2018)
Ahmed F Salem, Si Wang, Sandrine Billet, Jie-Fu Chen, Parima Udompholkul, Luca Gambini, Carlo Baggio, Hsian-Rong Tseng, Edwin M Posadas, Neil A Bhowmick, Maurizio Pellecchia
Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide-Drug Conjugate. Journal of medicinal chemistry 61 (5) (2018)
Luca Gambini, Ahmed F Salem, Parima Udompholkul, Xiao-Feng Tan, Carlo Baggio, Neh Shah, Alexander Aronson, Jikui Song, Maurizio Pellecchia
Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity in Vitro and in Cell. ACS chemical biology 13 (9) (2018)
Carlo Baggio, Parima Udompholkul, Elisa Barile, Maurizio Pellecchia
Enthalpy-Based Screening of Focused Combinatorial Libraries for the Identification of Potent and Selective Ligands. ACS chemical biology 12 (12) (2017)
Elisa Barile, Guya D Marconi, Surya K De, Carlo Baggio, Luca Gambini, Ahmed F Salem, Manoj K Kashyap, Januario E Castro, Thomas J Kipps, Maurizio Pellecchia
hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents. ACS chemical biology 12 (2) (2016)

Maurizio Pellecchia.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maurizio Pellecchia